Form 4 Filing: TETLOW SHARON Acquires Share Options in Structure Therapeutics Inc.

This Form 4 filing reports that TETLOW SHARON, a director at Structure Therapeutics Inc. (GPCR), was granted 39,453 share options on June 17, 2026. The options have an exercise price of $15.00 per share, which is equivalent to the fair market value on the grant date. These options will vest in equal monthly installments over the 12 months following the grant date, with full vesting occurring prior to the Issuer's 2027 annual shareholder meeting. The underlying securities are Ordinary Shares, with each American Depositary Share (ADS) representing three Ordinary Shares. Following the grant, TETLOW SHARON holds 39,453 shares underlying these options. The filing was signed by Jun Yoon, Attorney-in-Fact, on June 18, 2026.